CAS RN: 112522-64-2
Acetyldinaline
Product Availability
Choose a grade to view its available package options.
3 package records 2 with current stock 1 grade group
Grade
Moligand™, ≥98% (3)
In stock only
Batch No. Package Availability Inquiry
Batchno.20250709
10mg
In stock
Inquiry
Batchno.20260208
250mg
Out of stock
Inquiry
Batchno.20260626
50mg
In stock
Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥98%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 112522-64-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥98%
0
Out of Stock
Hong Kong
Inquiry
112522-64-2 / 4-acetamido-N-(2-aminophenyl)benzamide
Tacedinaline | ci-994 | 4-acetamido-N-(2-aminophenyl)benzamide
Standard CAS: 112522-64-2
Multi CAS: Yes
Basic Information
copy
CAS
112522-64-2 copy
Multi CAS
Yes copy
Molecular Formula
C15H15N3O2 copy
Molecular Weight
269.300000 copy
Exact Mass
269.116427 copy
SMILES
CC(=O)NC1=CC=C(C=C1)C(=O)NC2=CC=CC=C2N copy
InChI
InChI=1S/C15H15N3O2/c1-10(19)17-12-8-6-11(7-9-12)15(20)18-14-5-3-2-4-13(14)16/h2-9H,16H2,1H3,(H,17,19)(H,18,20) copy
InChIKey
VAZAPHZUAVEOMC-UHFFFAOYSA-N copy
Synonyms
Tacedinaline
ci-994
4-acetamido-N-(2-aminophenyl)benzamide
CI 994
Tacedinalina copy
Computed Properties
copy
Structural Parameters
Heavy atom count
20 copy
Aromatic heavy atom count
12 copy
Fraction Csp3
0.07 copy
Rotatable bonds
3 copy
H-bond acceptors
3 copy
H-bond donors
3 copy
Molar refractivity
79.55 copy
TPSA
84.22 copy
LogP / Solubility
WLOGP
2.48 copy
MLOGP
2.19 copy
XLogP3
1.3 copy
Consensus LogP
1.99 copy
Log S (ESOL)
-3.32 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.56 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.83 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.6 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
Yes copy
Synthetic Accessibility
1.5 copy
Safety & Transport
copy
Pictogram(s)
Irritant copy
Signal
Warning copy
GHS Hazard Statements
H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] copy
Precautionary Statement Codes
P264+P265, P280, P305+P351+P338, and P337+P317 copy